ライフサイエンスコーパス: incremental

1 ive was to evaluate the safety of our 30-min incremental 1-day protocol.

2 l lifetime QALY, but this gain would cost an incremental $77 290, leading to an ICER of $521 520 per

3 e addition of HB phase to DCEMRI provides an incremental accuracy of 4.5% compared to DCEMRI and DCEC

4 In the 12 mg dose group, incremental achievements of motor milestones (p<0.0001),

5 endothelial nitric oxide synthase, although incremental activation by insulin and shear stress was i

6 (ranging from pentamer to octamer), built by incremental addition of peptides to smaller oligomers, r

7 Incremental addition of Sequential Organ Failure Assessm

8 ional TiB2 particles and Ti solute with each incremental addition.

9 Despite incremental advances in diagnostics and therapeutics, es

10 ner as the STAT3 level decreased, along with incremental amounts of PRRSV inocula.

11 In an incremental analysis, incremental cost-effectiveness rat

12 For the base case incremental analysis, the actual overall health system c

13 ass of stochastic processes includes both an incremental and a pulsed component.

14 actors, and the genetic duet showed a strong incremental and synergistic impact over either mutation

15 black patients was associated with a higher incremental annual cost (the top 50% of blacks spent $11

16 d multiple chronic conditions (MCCs) and the incremental annual health care use, medical expenditures

17 An incremental approach can help to avoid these traps.

18 , typically spanning decades) by adopting an incremental approach-analyzing the expected consequences

19 ) values were calculated with the use of the incremental area under the curve (AUCi) method, and seru

20 dex (II) values were calculated by using the incremental area under the curve (AUCi) method.Adding ca

21 f glycemic excursion (MAGE) and postprandial incremental area under the curve (AUCpp).

22 After breakfast, the incremental area under the curve (iAUC) for plasma gluco

23 There was also a significantly lower incremental area under the curve (iAUC) for total peroxi

24 the postprandial response at 4 h and on the incremental area under the curve (iAUC) of plasma trigly

25 Incremental area under the curve (iAUC) over 0-3 h for g

26 by acidic beverages.As primary outcome, the incremental area under the curve for bread-derived blood

27 The incremental area under the plasma C-peptide concentratio

28 ) for both SIRS and severe sepsis (P < .001; incremental AUROC, 0.15; 95% CI, 0.09-0.22).

29 ng to compare, within the same participants, incremental BC detection by tomosynthesis and ultrasound

30 im analysis shows that ultrasound has better incremental BC detection than tomosynthesis in mammograp

31 er prospective study is needed to assess the incremental benefit beyond that offered by US.

32 with functional testing, did not provide an incremental benefit for QOL over 2 years of follow-up.

33 ver the study period in both groups, with no incremental benefit for the intervention.

34 on based on ECG metrics and to determine its incremental benefit in addition to the Framingham risk s

35 Despite ICR following PCI, there was no incremental benefit in angina or QOL measures by adding

36 bed could be considered to provide an added incremental benefit in decreasing IBTR after a shared di

37 tracking-derived Ecc and MSI provide minimal incremental benefit to SEE in predicting segmental recov

38 irst increases costs while providing minimal incremental benefit.

39 Joint treatment provided a small incremental benefit.

40 due to safety concerns, (2) FDA issuance of incremental boxed warnings added in the postmarket perio

41 he ASR analysis progresses over time, to the incremental 'brain states', measured using combined elec

42 The incremental C statistic for the RNA biosignatures over t

43 y care, excluding nursery, intermediate, and incremental care, to identify ICU stays.

44 , number of false-positive (FP) recalls, and incremental CDR for each modality; these were compared u

45 oups showed a significantly greater absolute incremental change (Delta) in total 25(OH)D when compare

46 Notably, the incremental change of daily death rate was most prominen

47 inephrine dose, the mean +/- SD post-arrival incremental change of the ln-transformed troponin-T at 7

48 st fitted by pulsed processes over models of incremental change, stationarity, and adaptive radiation

49 earning through evolution: adaptation though incremental changes in c-di-GMP network proteins acquire

50 and persistent changes in state despite only incremental changes in drivers.

51 Incremental changes of RA gradient slopes establish a co

52 ing is safe, but does not seem to provide an incremental clinical benefit in terms of functional outc

53 t multiple sites have not yielded consistent incremental clinical benefits, but have been associated

54 initially void of analyte ion is exposed to incremental concentrations of analyte in the sample.

55 th serum chloride (r=-0.46; P<0.001) with no incremental contribution from serum sodium (P=0.49).

56 ctions (BSI) but have not controlled for the incremental contribution of the individual components.

57 ssification improvement were used to compare incremental contributions of CAC score when added to the

58 t contributions to virulence underscores the incremental contributions to fitness of individual surfa

59 Strategies with an incremental cost effectiveness ratio below $100,000 per

60 tin plus paclitaxel chemotherapy produced an incremental cost effectiveness ratio of $198,867/QALY.

61 t strategy, NIVO followed by IPI produced an incremental cost effectiveness ratio of $90,871/QALY, an

62 each of the trial's outcomes in a series of incremental cost effectiveness ratios (ICERs).

63 f 0.199 QALYs compared with no surgery at an incremental cost of $30747, yielding an unfavorable ICER

64 nd 0.011 quality-adjusted life years with an incremental cost of $516 per patient compared with ICU w

65 The incremental cost per additional remission was $217 (95%

66 The BPA intervention had the lowest incremental cost per completed test ($24 with fixed star

67 in a cost-effective alternative to HPV4, the incremental cost per dose in girls should not exceed a m

68 artup costs, $3 without) and also the lowest incremental cost per new case identified after omitting

69 The lifetime incremental cost per QALY for noncontrast MR cholangiopa

70 ion was 0.08 (95% CI 0.03 to 0.13), the mean incremental cost per QALY gained was pound12 087.

71 2015 US$) associated with each strategy, and incremental cost per QALY gained.

72 We calculated the incremental cost per quality-adjusted life year (QALY) a

73 l observed treatment effect was genuine, the incremental cost per quality-adjusted life year was poun

74 When assuming no 4vHPV cross-protection, the incremental cost per quality-adjusted life-year (QALY) g

75 nonfatal myocardial infarction, or stroke), incremental cost per quality-adjusted life-year (QALY),

76 The incremental cost per quality-adjusted life-year gained w

77 Cost-effectiveness (incremental cost per quality-adjusted life-year gained)

78 tiveness of the VHS as measured by estimated incremental cost per self-harm event averted.

79 irst genetics appointment, there would be an incremental cost savings of A$5461 (US$4140) (95% CI, A$

80 initial tertiary presentation resulted in an incremental cost savings of A$9020 (US$6838) per additio

81 ibrillation provides clinical benefits at an incremental cost that represents reasonable value for mo

82 the 21-gene assay test results in an overall incremental cost to the health care system in the short-

83 iated with increased cost and improved QALY: incremental cost, $105398; incremental QALY, 0.39, with

84 The incremental cost, including cost of anticoagulant and mo

85 ient with STDR or DMO, respectively, with an incremental cost-effective ratio [ICER] of euro1096.88 f

86 al care [UC]) on treatment effectiveness and incremental cost-effectiveness in the 2 years after a na

87 To determine the incremental cost-effectiveness of a clinical practice gu

88 The incremental cost-effectiveness of SC compared with UC wa

89 etime medical costs in order to estimate the incremental cost-effectiveness of TAVR versus SAVR from

90 AVR by approximately $1,650 would lead to an incremental cost-effectiveness ratio <$50,000/QALY gaine

91 timate cumulative costs, graft survival, and incremental cost-effectiveness ratio (ICER - cost per ad

92 We used an incremental cost-effectiveness ratio (ICER = difference

93 The primary outcome was the incremental cost-effectiveness ratio (ICER) between test

94 he naloxone distribution strategy yielded an incremental cost-effectiveness ratio (ICER) of $323 per

95 adult screening and treatment for HBV has an incremental cost-effectiveness ratio (ICER) of $540 per

96 and incremental costs of $7,435, yielding an incremental cost-effectiveness ratio (ICER) of $94,917/Q

97 rgic rhinitis, may be cost-effective with an incremental cost-effectiveness ratio (ICER) of pound10 7

98 The incremental cost-effectiveness ratio (ICER) of vaccinati

99 The D.90, incremental cost-effectiveness ratio (ICER) was &OV0556;

100 An incremental cost-effectiveness ratio (ICER) was calculat

101 The incremental cost-effectiveness ratio (ICER) was euro6840

102 ar death, quality-adjusted life-year (QALY), incremental cost-effectiveness ratio (ICER), and net val

103 Incremental cost-effectiveness ratio (ICER), defined as

104 Over 2 years, the incremental cost-effectiveness ratio (ICER; compared wit

105 atment, high cost of HCV recurrence) was the incremental cost-effectiveness ratio associated with HCV

106 The incremental cost-effectiveness ratio for NHAS compared w

107 The incremental cost-effectiveness ratio for PCI compared wi

108 We evaluated the incremental cost-effectiveness ratio from a health syste

109 ario, oral targeted therapies resulted in an incremental cost-effectiveness ratio of $189,000 per qua

110 d $15.979 billion over 10 years, yielding an incremental cost-effectiveness ratio of $2720 and $1260

111 government's perspective, and results in an incremental cost-effectiveness ratio of $35663 (95% CI,

112 th ICU without telemedicine, resulting in an incremental cost-effectiveness ratio of $45,320 per addi

113 were $142,300 and $633,900, resulting in an incremental cost-effectiveness ratio of $473,400/quality

114 tic cost-effectiveness analysis estimated an incremental cost-effectiveness ratio of $50,265 with a w

115 t cost-effective in both populations with an incremental cost-effectiveness ratio of $74,255 (HCC) an

116 The incremental cost-effectiveness ratio of ECHO was $10,351

117 y interval (UI) 208-232] per vaccine, for an incremental cost-effectiveness ratio of pound20 000 per

118 will cease to be cost-effective with a mean incremental cost-effectiveness ratio of pound22 000 per

119 At the current price, the incremental cost-effectiveness ratio of statin plus PCSK

120 cost-effectiveness analysis to estimate the incremental cost-effectiveness ratio of telemedicine in

121 The incremental cost-effectiveness ratio was pound14 284 for

122 Terms sought included a combination of "incremental cost-effectiveness ratio" OR "economic evalu

123 ly cost-effective in terms of cost per QALY (incremental cost-effectiveness ratio, $92446).

124 cluded quality-adjusted life months (QALMs), incremental cost-effectiveness ratio, and net health ben

125 cluded quality-adjusted life months (QALMs), incremental cost-effectiveness ratio, and net health ben

126 Incremental cost-effectiveness ratio, net present value

127 lars, and cost-effectiveness expressed as an incremental cost-effectiveness ratio.

128 tiveness decision analysis model to estimate incremental cost-effectiveness ratios (cost per quality-

129 luate quality-adjusted life-years (QALY) and incremental cost-effectiveness ratios (ICER) of policy 1

130 In an incremental analysis, incremental cost-effectiveness ratios (ICERs) for screen

131 Outcome measures were incremental cost-effectiveness ratios (ICERs) in 2015 U.

132 ed quality-adjusted life years [QALYs]), and incremental cost-effectiveness ratios (ICERs) of the fou

133 Incremental cost-effectiveness ratios (ICERs) were calcu

134 Incremental cost-effectiveness ratios (ICERs) were deter

135 ew HIV infections, life-years and costs, and incremental cost-effectiveness ratios (ICERs), over 10-y

136 We calculated incremental cost-effectiveness ratios (ICERs), using dis

137 ts, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs).

138 values using the Consumer Price Index), and incremental cost-effectiveness ratios (ICERs).

139 s (30-40% chance of cost-effectiveness; mean incremental cost-effectiveness ratios [ICERs] pound45,20

140 literature and Medicare claims to determine incremental cost-effectiveness ratios and examined the n

141 Main outcomes were incremental cost-effectiveness ratios and numbers needed

142 5- and 20-year clinical outcomes, costs, and incremental cost-effectiveness ratios for (1) Current Pa

143 reserve treatment only for F3 patients; the incremental cost-effectiveness ratios for providing surg

144 Incremental cost-effectiveness ratios for surgery in all

145 usted life-year (QALY), were calculated with incremental cost-effectiveness ratios less than $100,000

146 To evaluate incremental cost-effectiveness ratios of 0.5-mg ranibizu

147 egies produced a gain in QALYs, resulting in incremental cost-effectiveness ratios of euro33072 (US $

148 Incremental cost-effectiveness ratios of ranibizumab com

149 d without baseline vision-impairing DME, the incremental cost-effectiveness ratios of ranibizumab the

150 lity-adjusted life years (QALYs), costs, and incremental cost-effectiveness ratios were calculated.

151 Over a 40 year time horizon, incremental cost-effectiveness ratios were pound22 201 (

152 Incremental cost-effectiveness ratios, expressed as doll

153 with an economic evaluation to calculate the incremental cost-effectiveness ratios, measured in cost

154 ted quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios.

155 H or ASCVD did not meet generally acceptable incremental cost-effectiveness thresholds and was estima

156 The primary outcomes were the incremental cost-effectiveness values ($/QALY) for each

157 PTSD cases among initial cases, and 10-year incremental cost-effectiveness.

158 Annual risk-adjusted incremental costs amounted to >$150 million.

159 l clinical benefits compared with SAVR, with incremental costs considered acceptable by current U.S.

160 was associated with QALY gains of 0.078 and incremental costs of $7,435, yielding an incremental cos

161 The effect size and incremental costs of BPA intervention (excluding startup

162 veness analysis, the primary outcome was the incremental costs of prevention per additional hospital

163 owed that relative to ZA every 3 months, the incremental costs per mean SRE avoided for denosumab ran

164 Overall health system costs and incremental costs were calculated.

165 e-year, 0.62 additional QALY, and $29 203 in incremental costs, equating to a cost per QALY gained of

166 Outcome Measures: Incremental costs, quality-adjusted life-years (QALYs),

167 ditions accounts for about half of estimated incremental costs.

168 luating histology, chemotherapy regimen, and incremental COX-2 expression did not demonstrate any adv

169 ealthy control subjects (n = 16 each) during incremental cycle exercise with diaphragmatic electromyo

170 al unnecessary treatments added by Ultra per incremental death averted by Ultra compared to outcomes

171 genes from Th1 to Th2 pattern but rather an incremental decline into immune dysfunction leading to m

172 om the TNT (Treating to New Targets), IDEAL (Incremental Decrease in End Points Through Aggressive Li

173 lar magnetic resonance (MR) images for their incremental diagnostic and prognostic information in pat

174 nd racial differences in stroke risk and the incremental diagnostic utility of novel stroke risk fact

175 DB, binary logistic regression evaluated the incremental diagnostic utility of the measures and neuro

176 puted tomography and nuclear imaging provide incremental diagnostic value and may be combined in a si

177 mical and functional assessment does not add incremental diagnostic value but guides clinical decisio

178 We suggest that these incremental differences in neural activity in the matern

179 ic value of the biomarkers was assessed with incremental discrimination improvement.

180 e increased the c-indexes by 0.000 to 0.004 (incremental discrimination index, p < 0.01 for all excep

181 ry shock or who are periarrest, we recommend incremental doses of high-dose insulin (1D) and IV lipid

182 ory to the first-line treatments, we suggest incremental doses of high-dose insulin therapy if myocar

183 t ESMO benefit thresholds had a lower median incremental drug cost than did those that did not meet b

184 ups of each randomised controlled trial (ie, incremental drug cost) were derived from 2016 average wh

185 re available, ASCO benefit score and monthly incremental drug costs were negatively correlated (rho=-

186 n older individuals, both at rest and during incremental dynamic exercise.

187 ci were identified even when each one was of incremental effect, consistent with control of ABA accum

188 f clusters and the inability to evaluate the incremental effectiveness of individual components of th

189 heterization via radial access and performed incremental exercise using a supine cycle ergometer.

190 For replacement patients, incremental expenditures at 1 year by treatment intensit

191 demonstrate our newly-developed 'controlled incremental filtration' (CIF) approach to perform high-t

192 nd an increase in tryptophan fluorescence at incremental fluences, as well as linear phase diagrams.

193 their final functional configuration through incremental folding with many intermediate steps in the

194 d data (relative risk reduction of 50%), the incremental gain in quality-adjusted life-years (QALYs)

195 The sensitivity analysis showed that the incremental gain of QALY ranged from 0.0041 to 0.030.

196 on during heart surgery does not seem to add incremental harm, there is insufficient evidence of bene

197 [95% CI, 2.49-2.60]; P < .001) There was an incremental hazard according to depression treatment typ

198 e average Ac-He distances, and also with the incremental He binding energies.

199 Incremental heating of 49 individual Bishop Tuff (BT) sa

200 Single-crystal incremental heating provides leverage with which to inte

201 2.0% vs 18.1%; trend test P < 0.001) with an incremental impact as complications accrued (6.7% 1 comp

202 L versus UC alone had clinically significant incremental improvement in KCCQ and FACIT-Pal scores fro

203 These enhancements provide incremental improvement in structure database searches a

204 ual loss, whereas it may be harder to detect incremental improvement in visual function in those with

205 oach inherent to classification will provide incremental improvement to present diagnostic constructs

206 d age at first use of optical correction and incremental improvement with addition of the reason.

207 ever, plant breeding is currently limited by incremental improvements in quantitative traits that oft

208 e purpose of this study was to determine the incremental increase in breast cancer detection when BSG

209 Incremental increase in cancer detection was calculated

210 ing artificial nutrient media brings only an incremental increase in cultivability.

211 d to establish the magnitude of risk and the incremental influence of insulin dependency by examining

212 independent parameter for outcome and offers incremental information beyond LV EF and the presence of

213 yndrome continues to represent an important, incremental insult and risk modifier of acute and longer

214 ated neural activity better than a canonical incremental learning model.

215 ing novel multivariate techniques to compare incremental 'machine states', generated as the ASR analy

216 were coadministered with prostacyclin in an incremental manner (0.04, 0.4, 4, 40 and 400 mum each fo

217 this organism is very well described by the incremental model, suggesting a common strategy for cell

218 ic and clinical consequences associated with incremental morbidity and death.

219 The mechanisms by which PRA confers an incremental mortality risk in sensitized patients, and t

220 V-PASs), consisting of CVs performed between incremental motor movements.

221 junctions, an activity that can explain the incremental nature of telomeric C-strand synthesis follo

222 The incremental number needed to vaccinate among women is 5.

223 ays a critical role in the estimation of the incremental oil recovery.

224 The incremental operative risk of adding ARE to AVR has not

225 The incremental overall cost to the health service per kg we

226 it, and generalized linear model to estimate incremental per patient per month costs, and used simula

227 Microvascular obstruction provided no incremental predictive accuracy above SEE.

228 ailable on hospital arrival provides minimal incremental predictive value compared with the National

229 is of GDM, with significant associations and incremental predictive value detected as early as gestat

230 This study sought to compare the incremental predictive value of 7 different frailty scal

231 ), BNPratio was a powerful, independent, and incremental predictor of mortality after diagnosis (haza

232 thod, a normalization procedure suitable for incremental preprocessing of individual methylation arra

233 GLS provided incremental prognostic information beyond the Framingham

234 d from the inferior myocardial wall provided incremental prognostic information for VT/VF over clinic

235 ict ventricular tachyarrhythmias and provide incremental prognostic information over clinical and con

236 deformation in the inferior region provided incremental prognostic information over clinical and ech

237 ral population, GLS provides independent and incremental prognostic information regarding long-term r

238 and circulating secretoneurin levels provide incremental prognostic information to established risk i

239 In addition, cTnI provided no incremental prognostic information to the Framingham Car

240 longer-term cardiovascular mortality and (2) incremental prognostic use of indexing aortic root to pa

241 ndergoing redo AVR, baseline LV-GLS provides incremental prognostic use over established predictors a

242 sought to determine whether LV-GLS provides incremental prognostic use.

243 resting LV-GLS and exercise testing provide incremental prognostic utility in asymptomatic patients

244 th increased long-term mortality and (2) the incremental prognostic utility of indexing aortic root t

245 -GLS) and brain natriuretic peptide provided incremental prognostic utility.

246 lic function and longitudinal strain provide incremental prognostic value beyond conventional measure

247 Objective: To assess the incremental prognostic value of biomarkers that reflect

248 The incremental prognostic value of lateral MAPSE was assess

249 e likelihood ratio test showed a significant incremental prognostic value of LAVI and GLS (P<0.001) a

250 imaging into a simple risk score that showed incremental prognostic value over clinical risk factors

251 For a 6-month time window, the average incremental QALY benefit was 0.021.

252 nd improved QALY: incremental cost, $105398; incremental QALY, 0.39, with an ICER of $268637 per QALY

253 Even assuming the lowest incremental QALYs for the most expensive moisturizer, th

254 se profiles were evaluated using the maximum incremental reactivity (MIR) scale.

255 n to adult women is modest, with the largest incremental reductions in the incidence of HPV infection

256 - and long-term risk conferred by DM and the incremental risk conferred by insulin dependency in the

257 The incremental risk did not vary by stent type.

258 e of HLA molecules represent independent and incremental risk factors for kidney graft failure (GF) b

259 pediatric intensive care units to define the incremental risk of death and complications associated w

260 e HLA-DRB1 molecule account for an important incremental risk of GF.

261 HLA-DRB1 molecule account for a significant incremental risk that was independent of the well-known

262 mes raises dual-use concerns, we believe the incremental risks are outweighed by potential benefits.

263 we investigated how working memory (WM) and incremental RL processes interact to guide human learnin

264 tates, but high budgetary costs suggest that incremental rollout of ECHO may be best.

265 Incremental selection within a population, defined as li

266 This work is an important incremental step for clinical genomics and genetic epide

267 The Non-Isothermal Diffusion Incremental Step model represents a significant improvem

268 reys (Petromyzon marinus) of either sex that incremental stimulation of a region homologous to the ma

269 Incremental stress relaxation experiments were performed

270 eprilysin inhibition (ARNI) therapy provided incremental survival benefit to patients with heart fail

271 deally, policies must move beyond the purely incremental; that is, policies that merely tinker at the

272 f mortality in patients with LV dysfunction, incremental to common clinical and cardiac MR risk facto

273 RVESRI was incremental to risk prediction scores in pulmonary arter

274 tial benefits of PCSK9 monoclonal antibodies incremental to statins in on-going clinical end point tr

275 actly how much do repeated measurements add, incremental to the information provided by baseline meas

276 ly scaled index of end-systolic dimension is incremental to well-validated prognostic scores in pulmo

277 e as large as ~40% within an extremely short incremental track length of ~20 nm.

278 put Expression of Soluble Proteins by Random Incremental Truncation (ESPRIT) technique to identify di

279 evaluated-resulting in a median ratio of 38 incremental unnecessary treatments added by Ultra per in

280 Incremental use, expenditures, and lost productivity wer

281 played criterion and construct validity, had incremental utility at low DB levels (CBS and PPA) and w

282 Our results demonstrate that incremental vaccination against a single chemical specie

283 g clinical use, posing questions about their incremental value compared with disease-specific multige

284 ssment of (18)F-FDG PET provides statistical incremental value for predicting pathCR after preoperati

285 n approximately 30% of patients and provides incremental value in addition to left ventricular ejecti

286 dge gaps, including the lack of data showing incremental value in clinical practice.

287 risk, to support decision-making and, since incremental value is modest when used as a sole criterio

288 The incremental value of a repeated induced sputum (IS) samp

289 Purpose To determine the incremental value of clinical data in patients with ultr

290 In this study, we examined the incremental value of considering right ventricular eject

291 ying impact of IPTp-SP across Africa and the incremental value of enhancing IPTp-SP uptake to match c

292 racy of CCTA, SPECT, and PET and explore the incremental value of hybrid imaging compared with fracti

293 Likelihood ratio test indicated incremental value of LA volume assessment (P=0.011) on t

294 e to draw definite conclusions regarding the incremental value of NT-proBNP testing in patients who f

295 een acute and healed stages, underlining the incremental value of T2 mapping.

296 ndependently associated with AF and provided incremental value over well-known predictors of AF.

297 expensive, reproducible biomarker that added incremental value to current practice guidelines in athe

298 The incremental values of RV free wall longitudinal strain a

299 stablishes millions of parallel channels for incremental visual field analysis.

300 To examine incremental weight gain, linear growth, and clinical fea